Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dendritic Cell-Based Immunotherapy in Advanced Sarcoma and Neuroblastoma Pediatric Patients: Anti-cancer Treatment Preceding Monocyte Harvest Impairs the Immunostimulatory and Antigen-Presenting Behavior of DCs and Manufacturing Process Outcome.
Hlavackova E, Pilatova K, Cerna D, Selingerova I, Mudry P, Mazanek P, Fedorova L, Merhautova J, Jureckova L, Semerad L, Pacasova R, Flajsarova L, Souckova L, Demlova R, Sterba J, Valik D, Zdrazilova-Dubska L. Hlavackova E, et al. Among authors: semerad l. Front Oncol. 2019 Oct 25;9:1034. doi: 10.3389/fonc.2019.01034. eCollection 2019. Front Oncol. 2019. PMID: 31709173 Free PMC article.
The impact of centralised care of younger AML patients on treatment results: a retrospective analysis of real-world data from a national population-based registry.
Semerad L, Sustkova Z, Cetkovsky P, Jindra P, Koristek Z, Novak J, Racil Z, Szotkowski T, Weinbergerova B, Zak P, Pospisil Z, Baranova J, Mayer J. Semerad L, et al. Acta Oncol. 2021 Jun;60(6):818-823. doi: 10.1080/0284186X.2021.1917002. Epub 2021 May 28. Acta Oncol. 2021. PMID: 34048310 No abstract available.
[New Drugs in the Treatment of Acute Myeloid Leukemia in the Elderly].
Šustková Z, Čulen M, Semerád L, Ježíšková I, Dvořáková D, Ráčil Z, Mayer J. Šustková Z, et al. Among authors: semerad l. Klin Onkol. 2017 Summer;30(3):190-196. doi: 10.14735/amko2017190. Klin Onkol. 2017. PMID: 28612615 Review. Czech.
Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspects.
Culen M, Borsky M, Nemethova V, Razga F, Smejkal J, Jurcek T, Dvorakova D, Zackova D, Weinbergerova B, Semerad L, Sadovnik I, Eisenwort G, Herrmann H, Valent P, Mayer J, Racil Z. Culen M, et al. Among authors: semerad l. Oncotarget. 2016 May 31;7(22):33016-24. doi: 10.18632/oncotarget.9108. Oncotarget. 2016. PMID: 27145281 Free PMC article.
Novel complex mutation in NPM1 gene in patient with acute myeloid leukemia.
Jeziskova I, Semerad L, Dvorakova D, Janeckova V, Culen M, Kunetkova T, Mayer J, Racil Z. Jeziskova I, et al. Among authors: semerad l. Leuk Lymphoma. 2017 Mar;58(3):746-748. doi: 10.1080/10428194.2016.1213832. Epub 2016 Aug 3. Leuk Lymphoma. 2017. PMID: 27484360 No abstract available.
Prognostic significance of mutation profile at diagnosis and mutation persistence during disease remission in adult acute myeloid leukaemia patients.
Folta A, Culen M, Jeziskova I, Herudkova Z, Tom N, Hlubinkova T, Janeckova V, Durinikova A, Vydra J, Semerad L, Dvorakova D, Remesova H, Cerovska E, Cetkovsky P, Jindra P, Szotkowski T, Zak P, Mayer J, Racil Z. Folta A, et al. Among authors: semerad l. Br J Haematol. 2019 Jul;186(2):300-310. doi: 10.1111/bjh.15916. Epub 2019 Apr 9. Br J Haematol. 2019. PMID: 30968396 Free article. Clinical Trial.
Clonal hierarchy of main molecular lesions in acute myeloid leukaemia.
Herudkova Z, Culen M, Folta A, Jeziskova I, Cerna J, Loja T, Tom N, Smejkal J, Semerad L, Dvorakova D, Mayer J, Racil Z. Herudkova Z, et al. Among authors: semerad l. Br J Haematol. 2020 Aug;190(4):562-572. doi: 10.1111/bjh.16341. Epub 2019 Dec 10. Br J Haematol. 2020. PMID: 31822038 Free article.
Analysis of serum lipids, cardiovascular risk, and indication for statin use during nilotinib and imatinib therapy in de novo CML patients - results from real-life prospective study.
Horňák T, Semerád L, Žáčková D, Weinbergerová B, Šustková Z, Procházková J, Bělohlávková P, Stejskal L, Rohoň P, Faber E, Žák P, Mayer J, Ráčil Z. Horňák T, et al. Among authors: semerad l. Leuk Lymphoma. 2020 Feb;61(2):494-496. doi: 10.1080/10428194.2019.1672054. Epub 2019 Oct 3. Leuk Lymphoma. 2020. PMID: 31580157 No abstract available.
20 results